Personalized Drug Discovery Group is an international research group situated in LIH’s Department of Oncology.


Team members

Yong-Jun Kwon

Group leader

Tatiana Michel

Scientist Project Manager

Victoria El Khoury


Hichul Kim


Vanessa Barthelemy


Jennifer Phan

PhD student

Luxembourg Institute of Health

The Luxembourg Institute of Health (LIH) is a public research organisation at the forefront of biomedical sciences. LIH aims to perform research that transcends the boundaries of individual diseases and that can be tangibly applied in the clinical practice to address unmet needs, thus positively affecting health outcomes for patients. This translational and transversal research strategy, combined to the increasing appreciation of the role of the immune system in determining disease, has led LIH to focus on four priority areas: cancer, immunological disorders, neurodegenerative diseases, preventive medicine.